More importantly, we showed that both genetically reducing and ASO treatment for Tau reduction effectively alleviated social defects, stereotyped and repetitive behavior, circadian rhythm dysregulation, and spine abnormality in Fmr1 KO mice, indicating that Tau reduction is also a promising strategy for FXS treatment. This evidence concerns the gene MAPT and fragile X syndrome.